Stanford Team Develops Mathematical Model to Assess Effectiveness of Early-Stage Cancer Biomarkers | GenomeWeb

By Uduak Grace Thomas

Researchers at Stanford University have created a mathematical model that sheds light on the correlation between blood biomarker levels and tumor size — information that can determine how well certain biomarkers may be suited for early cancer detection.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.